With NHS-muIL12 treatment, the reductions of MB49luc bladder tumor growth was not accompanied by any discernable increase in the number of CD4+ and CD8+ effector T cells (Fig. 2d, e), yet their activation status was increased (Fig. 5a, b). This evidence concerns the gene CD4 and urinary bladder neoplasm.